Measurement of thoracic fluid content in heart failure: The role of impedance cardiography

AACN Advanced Critical Care

Volumn 19, Issue 1, 2008, Pages 47-55

  Folan, Lynn ^a   Funk, Marjorie ^b  

^a University of Connecticut   (United States)

^b YALE UNIVERSITY   (United States)

Author keywords

Heart failure; Impedance cardiography; Thoracic fluid

Indexed keywords

BODY FLUID; HEART FAILURE; HUMAN; IMPEDANCE CARDIOGRAPHY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; THORACIC CAVITY;

BODY FLUIDS; CARDIOGRAPHY, IMPEDANCE; HEART FAILURE; HUMANS; THORACIC CAVITY;

EID: 45149124008     PISSN: 15597768     EISSN: 15597768     Source Type: Journal    
DOI: 10.1097/01.AACN.0000310751.93287.42     Document Type: Article

References (23)

1. Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to update the 2001 guidelines for the evaluation and management of heart failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation. 2005;112:1825-1852.
2. Yu C-M, Wang L, Chau E, et al. Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and easibility of early warning preceding hospitalization. Circulation. 2005;112:841-848.
3. Shochat M, Charach G, Meyler S, et al. Internal thoracic impedance monitoring: a novel method for the preclinical detection of acute heart failure. Cardiovasc Revasc Med. 2006;7:41-45.
4. Abraham WT. Intrathoracic impedance monitoring for early detection of impending heart failure decompensation. Congest Heart Fail. 2007;13:113-115.
5. The ESCAPE Investigators and ESCAPE Study Coordinators. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. JAMA. 2005;294:1625-1633.
6. Felker GM, Petersen JW, Mark DB. Natriuretic peptides in the diagnosis and management of heart failure. Can Med Assoc J. 175:611-617.
7. Thom O, Taylor D. Transthoracic electrical bioimpedance: a means of filling the void? Emerg Med Australas. 2005;17:249-262.
8. Veale WN Jr, Morgan JH, Beatty JS, Sheppard SW, Dalton MI, Van De Water JM. Hemodynamic and pulmonary fluid status in the trauma patient: are we slipping? Am Surg. 2005;71:621-626.
9. Lasater M, Von Rueden KT. Outpatient cardiovascular management utilizing impedance cardiography. AACN Clin Issues. 2003;14:240-250.
10. Peacock WF, Summers RL, Vogel J, Emerman CE. Impact of impedance cardiography on diagnosis and therapy of emergent dyspnea: the ED-IMPACT trial. Acad Emerg Med. 2006;13:365-371.
11. Wong GC, Ayas NT. Clinical approaches to the diagnosis of acute heart failure. Curr Opin Cardiol. 22:207-213.
12. Strobeck JE, Silver MA. Beyond the four quadrants: the critical and emerging role of impedance cardiography in heart failure. Congest Heart Fail. 2004;10(2)(suppl 2):1-6.
13. Albert NM, Hail MD, Li J, Young JB. Equivalence of the bioimpedance and thermodilution methods in measuring cardiac output in hospitalized patients with advanced, decompensated chronic heart failure. Am J Crit Care. 2004;13:469-479.
14. Funk M, Nyström KV, Riordan M, Hutchinson C. Bioimpedance monitoring in patients with heart failure. Eur J Cardiovasc Nurs. 2005;4:51-52.
15. Drazner MH, Thompson B, Rosenberg PB, et al. Comparison of impedance cardiography with invasive hemodynamic measurements in patients with heart failure secondary to ischemic or nonischemic cardiomyopathy. Am J Cardiol. 2002;89:993-995.
16. Campos PC, D'Cruz IA, Johnson LS, Malhotra A, Ramanathan KB, Weber KT. Functional valvular incompetence in decompensated heart failure: noninvasive monitoring and response to medical management. Am J Med Sci. 2005;329:217-221.
17. Packer M, Abraham WT, Mehra MR, et al. Utility of impedance cardiography for the identification of shortterm risk of clinical decompensation in stable patients with chronic heart failure. J Am Coll Cardiol. 2006;47:2245-2252.
18. Peacock WF, Kies P, Albert NM, White RD, Janz BA, Emerman CL. Bioimpedance monitoring: better than chest xray for predicting abnormal pulmonary fluid? Congest Heart Fail. 2000;6:32-35.
19. Vollmann D, Lüthje L, Drescher T, et al. P6-88: devicebased monitoring of intrathoracic impedance to alert patients with chronic heart failure of cardiac decompensation: algorithm performance and correlation with NT-proBNP. Heart Rhythm. 2006;3(5)(suppl 1): S330-S331.
20. Abraham WT, Foreman B, Fishel R, Haas G, Moe B. Fluid accumulation status trial (FAST). Heart Rhythm. 2005; 2(5)(suppl 1):S65-S66.
21. Knackstedt C, Mischke K, Schimpf T, et al. P2-49: intrathoracic impedance measurement (OptiVoltM) in patients with congestive heart failure. Heart Rhythm. 2006;3(5)(suppl 1):S154-S155.
22. Noninvasive Medical Technologies Inc. Optimizes therapeutic decision making. http://nmtinc.org/optimizes-therapeutic.html. Accessed January 4, 2008.
23. Van De Water JM, Mount BE, Chandra D, Mitchell BP, Woodruff TA, Dalton ML. TFC (thoracic fluid content): a new parameter for assessment of changes in chest fluid volume. Am Surg. 2005;71:81-86.